November 16th, 2025

Las Vegas, NV / CRWE PRESS RELEASE / November 16, 2025 - Among the companies expected to release their financial results on Wednesday, November 19, are: Bullish (NYSE: BLSH), a digital asset platform, will report its third-quarter 2025 results bef. Read more

September 14th, 2025

Las Vegas, NV / CRWE PRESS RELEASE / September 14, 2025 - On Wednesday, September 17, several well-known names are scheduled to announce earnings, including: General Mills, Inc. (NYSE: GIS), the packaged foods giant, will post its fiscal first-qua. Read more

October 23rd, 2023

Stifel upgraded Pinterest, Inc. (NYSE: PINS), a popular social media platform, from Hold to Buy and raised the price target from $27 to $32. Based on the closing price of $25.96 on Friday, the upgraded price target suggests a potential upside of $. Read more

October 18th, 2023

Shares of Sage Therapeutics, Inc. (Nasdaq: SAGE), a leading biopharmaceutical company specializing in neurological and neuropsychiatric disorders, surged over 5% in pre-market trading after the company said that the U.S. Food and Drug Administration . Read more

October 16th, 2023

Rite Aid Corporation (NYSE: RAD) said that it has initiated a Chapter 11 filing, outlining a financial restructuring plan to reduce debt, increase financial flexibility, and support key business initiatives. The move aims to continue serving the near. Read more

October 13th, 2023

BlackRock, Inc. (NYSE: BLK), an investment management and financial services company, reported third-quarter 2023 adjusted earnings per share (EPS) of $10.91, surpassing the consensus EPS estimate of $8.26. However, the company's revenue for the peri. Read more

October 09th, 2023

HC Wainwright & Co. has initiated coverage on Scilex Holding Company (Nasdaq: SCLX), a pharmaceutical company, with a Buy rating and a price target of $12. Closing at $1.57 on Friday, this price target suggests a substantial potential upside of $1. Read more

October 06th, 2023

Truist Securities upgraded Frontdoor, Inc. (Nasdaq: FTDR), a home service plan provider, elevating its rating from Hold to Buy and adjusting the price target from $40 to $42. With $FTDR closing at $29.31 on Thursday, the revised price target sugge. Read more

October 05th, 2023

AirSculpt Technologies, Inc. (Nasdaq: AIRS), a medical technology company specializing in body contouring procedures, has provided a positive outlook for its third-quarter 2023 revenue, with expectations set at approximately $46.5 million, surpassing. Read more

October 04th, 2023

UBS upgraded Fluor Corporation (NYSE: FLR), a leading engineering and construction company, from Neutral to Buy and raised the price target from $35 to $47 With $FLR closing at $34.62 on Tuesday, the new price target implies a potential upside of . Read more

October 02nd, 2023

UBS has initiated coverage on Nextracker Inc. (Nasdaq: NXT), a notable player in the energy technology sector, with a Buy rating and a price target of $50. Closing at $40.16 on Friday, this price target suggests a substantial potential upside of $. Read more

September 27th, 2023

UBS has initiated coverage on Blink Charging Co. (Nasdaq: BLNK), a leading provider of electric vehicle charging services, with a Buy rating and a price target of $7. With $BLNK closing at $2.93 on Tuesday, the price target suggests a significant . Read more

September 26th, 2023

Shares of Soleno Therapeutics, Inc. (Nasdaq: SLNO) soared over 300% in pre-market trading following the release of positive top-line results from Study C602.  The study, which focused on the long-term treatment of Prader-Willi syndrome (PWS) . Read more

September 25th, 2023

Shares of Ardelyx, Inc. (Nasdaq: ARDX) surged in pre-market trading after its collaboration partner Kyowa Kirin Co., Ltd. received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the New Drug Application (NDA) for tenapan. Read more

September 20th, 2023

General Mills, Inc. (NYSE: GIS), a notable food products manufacturer, reported first-quarter fiscal 2024 adjusted earnings of $1.09 per share, surpassing the consensus EPS estimate of $1.08. Additionally, its quarterly sales amounted to $4.90 billio. Read more